SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Belcaro, G.
Right arrow Articles by Barsotti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belcaro, G.
Right arrow Articles by Barsotti, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Fibrinolytic Enhancement in Diabetic Microangiopathy with Defibrotide

G. Belcaro

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

C. Marelli

P. Pomante

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

G. Laurora

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

M.R. Cesarone

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

A. Ricci

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

R. Girardello

A. Barsotti

Microcirculation Laboratory, Cardiovascular Institute, G.D'Annunzio University, Chieti and Roussel-Pharma, Milan, Italy

Skin microcirculation was evaluated in 117 patients with diabetic microan giopathy over a period of six months. They were divided into two groups. Group 1 (64 patients) was treated with oral defibrotide, a new profibrinolytic drug, in association with diet and oral antidiabetic drugs. Group 2 (53 patients) was treated only with diet and antidiabetic agents.

The microcirculation was studied by means of laser-Doppler flowmetry trans cutaneous partial pressure of oxygen and carbon dioxide pressure measurements, and evaluation of capillary filtration.

After six months, patients in group 1 improved their microcirculatory parameters in association with an improvement in signs and symptoms.

Moreover, 30 patients in group 1 and 36 in group 2 were followed up for eighteen months, and the authors observed that the deterioration of the microcir culatory parameters was significantly slowed in diabetics treated with defibrotide.

A decrease in plasma fibrinogen during defibrotide treatment was observed in all treated patients in association with an increased fibrinolytic activity.

In conclusion, it appears that defibrotide, enhancing fibrinolysis, improved the microcirculation in diabetics, preventing further, progressive deterioration.

Angiology, Vol. 43, No. 10, 793-800 (1992)
DOI: 10.1177/000331979204301001
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement